Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rybak

Showing results (601-610 of 2,586) with videos related to

Pageof 259
Sort By:
Journal of Theoretical Biology|September 29, 2009
Are bird song complexity and song sharing shaped by habitat structure? An information theory and statistical approachElodie Briefer, Tomasz S Osiejuk, Fanny Rybak, et al.
Pneumonologia I Alergologia Polska|October 27, 2011
[Two siblings with an IL-12 and IFN-γ production disorder diagnosed with pulmonary mycobacteriosis caused by M. kansasii. Mendelian susceptibility to mycobacterial infection: an overview of literature]Piotr Nalepa, Magdalena Strach, Marta Rybak-Bąk, et al.
Pharmacotherapy|January 1, 1990
The triazole antifungal agents: a review of itraconazole and fluconazoleE M Bailey, D J Krakovsky, M J Rybak
Cancer|November 1, 1995
A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinomaW M Stadler, M E Rybak, N J Vogelzang
Clinical Immunology and Immunopathology|April 1, 1997
Safety evaluation of recombinant human interleukin-4. II. Clinical studiesM W Leach, M E Rybak, I Y Rosenblum
The Journal of Antimicrobial Chemotherapy|September 24, 2014
The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSAKatie E Barber, Brian J Werth, Michael J Rybak
Pharmacotherapy|December 5, 2013
Vancomycin: over 50 years later and still a work in progressMichael J Rybak, John C Rotschafer, Keith A Rodvold
Infectious Diseases and Therapy|September 6, 2015
Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive InfectionsJordan R Smith, Karrine D Roberts, Michael J Rybak
Infectious Diseases and Therapy|December 6, 2014
A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumanniiKimberly C Claeys, Anna D Fiorvento, Michael J Rybak
International Journal of Molecular Sciences|October 14, 2022
Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are HeadingZuzanna Świerczewska, Miłosz Lewandowski, Agnieszka Surowiecka, et al.
Pageof 259

Showing results (601-610 of 2,586) with videos related to

Sort By:
Pageof 259
Journal of Theoretical Biology|September 29, 2009
Are bird song complexity and song sharing shaped by habitat structure? An information theory and statistical approachElodie Briefer, Tomasz S Osiejuk, Fanny Rybak, et al.
Pneumonologia I Alergologia Polska|October 27, 2011
[Two siblings with an IL-12 and IFN-γ production disorder diagnosed with pulmonary mycobacteriosis caused by M. kansasii. Mendelian susceptibility to mycobacterial infection: an overview of literature]Piotr Nalepa, Magdalena Strach, Marta Rybak-Bąk, et al.
Pharmacotherapy|January 1, 1990
The triazole antifungal agents: a review of itraconazole and fluconazoleE M Bailey, D J Krakovsky, M J Rybak
Cancer|November 1, 1995
A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinomaW M Stadler, M E Rybak, N J Vogelzang
Clinical Immunology and Immunopathology|April 1, 1997
Safety evaluation of recombinant human interleukin-4. II. Clinical studiesM W Leach, M E Rybak, I Y Rosenblum
The Journal of Antimicrobial Chemotherapy|September 24, 2014
The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSAKatie E Barber, Brian J Werth, Michael J Rybak
Pharmacotherapy|December 5, 2013
Vancomycin: over 50 years later and still a work in progressMichael J Rybak, John C Rotschafer, Keith A Rodvold
Infectious Diseases and Therapy|September 6, 2015
Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive InfectionsJordan R Smith, Karrine D Roberts, Michael J Rybak
Infectious Diseases and Therapy|December 6, 2014
A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumanniiKimberly C Claeys, Anna D Fiorvento, Michael J Rybak
International Journal of Molecular Sciences|October 14, 2022
Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are HeadingZuzanna Świerczewska, Miłosz Lewandowski, Agnieszka Surowiecka, et al.
Pageof 259